---
$id: https://graph.org.ai/products/commodity/51161540
$type: Product
source: UNSPSC
code: "51161540"
title: "Flufylline"
class: "51161500"
classTitle: "Antiasthmatic drugs"
family: "51160000"
familyTitle: "Drugs affecting the respiratory tract"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Flufylline

**UNSPSC Code**: 51161540
**Class**: [Antiasthmatic drugs](Antiasthmatic drugs.mdx)
**Family**: [Drugs affecting the respiratory tract](../Drugs affecting the respiratory tract.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a phosphodiesterase inhibitor and bronchodilator with the molecular formula C21H24FN5O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier O8G173034U, chemically known as 1h-purine-2,6-dione, 7-(2-(4-(4-fluorobenzoyl)-1-piperidinyl)ethyl)-3,7-dihydro-1,3-dimethyl- but generally known as flufylline, which bears US NIH Compound Identifier 71255. European Medicines Agency schedules Flufylline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07689MIG. The term FLUFYLLINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 37, No. 6, 1983, List 23). FLUFYLLINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule flufylline under HS 29395900 and SITC 54145. As of Q4 2014, FLUFYLLINE remains the US FDA Preferred Term for this commodity. Flufylline bears US NLM identifiers UMLS ID C0060489 and NCI Concept Code C65712. SMILES: FC1CCC(C(=O)C2CCN(CC2)CCN2C3C(N(C(=O)N(C3=O)C)C)NC2)CC1.

